Exosomal miRNA: Small Molecules, Big Impact in Colorectal Cancer.


Journal

Journal of oncology
ISSN: 1687-8450
Titre abrégé: J Oncol
Pays: Egypt
ID NLM: 101496537

Informations de publication

Date de publication:
2019
Historique:
received: 24 05 2019
accepted: 10 08 2019
entrez: 19 11 2019
pubmed: 19 11 2019
medline: 19 11 2019
Statut: epublish

Résumé

Colorectal cancer (CRC) is one of the major causes of cancer-related deaths worldwide. Tumor microenvironment (TME) contains many cell types including stromal cells, immune cells, and endothelial cells. The TME modulation explains the heterogeneity of response to therapy observed in patients. In this context, exosomes are emerging as major contributors in cancer biology. Indeed, exosomes are implicated in tumor proliferation, angiogenesis, invasion, and premetastatic niche formation. They contain bioactive molecules such as proteins, lipids, and RNAs. More recently, many studies on exosomes have focused on miRNAs, small noncoding RNA molecules able to influence protein expression. In this review, we describe miRNAs transported by exosomes in the context of CRC and discuss their influence on TME and their potential as circulating biomarkers. This overview underlines emerging roles for exosomal miRNAs in cancer research for the near future.

Identifiants

pubmed: 31737071
doi: 10.1155/2019/8585276
pmc: PMC6815599
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

8585276

Informations de copyright

Copyright © 2019 Valentin Vautrot et al.

Déclaration de conflit d'intérêts

The authors declare that they have no conflicts of interest.

Références

J Cell Biochem. 2018 Sep 1;:null
pubmed: 30171732
Neuropathol Appl Neurobiol. 2006 Feb;32(1):51-63
pubmed: 16409553
Chronic Dis Transl Med. 2018 Sep 03;4(3):156-163
pubmed: 30276362
Int J Biochem Cell Biol. 2012 Sep;44(9):1574-84
pubmed: 22728313
Oncol Rep. 2015 Jan;33(1):67-73
pubmed: 25394686
Mol Cell Proteomics. 2013 Mar;12(3):587-98
pubmed: 23230278
J Natl Cancer Inst. 2015 Nov 22;108(3):
pubmed: 26598503
Aging (Albany NY). 2017 Dec 28;9(12):2666-2694
pubmed: 29283887
CA Cancer J Clin. 2014 Mar-Apr;64(2):104-17
pubmed: 24639052
PLoS One. 2012;7(3):e30679
pubmed: 22427800
Int J Mol Sci. 2016 Feb 06;17(2):171
pubmed: 26861302
J Cell Physiol. 2018 Sep;233(9):6660-6668
pubmed: 29206292
Br J Cancer. 2018 Sep;119(6):744-755
pubmed: 30220706
Proteomics. 2013 May;13(10-11):1672-86
pubmed: 23585443
Transl Oncol. 2018 Apr;11(2):221-232
pubmed: 29367070
Nat Commun. 2018 Feb 22;9(1):771
pubmed: 29472616
Sci Rep. 2017 Jun 23;7(1):4150
pubmed: 28646161
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Nature. 2004 Nov 11;432(7014):231-5
pubmed: 15531879
J Extracell Vesicles. 2014 Mar 26;3:null
pubmed: 24683445
J Clin Invest. 2008 Jan;118(1):89-99
pubmed: 18064304
Bioessays. 2010 Oct;32(10):894-904
pubmed: 21105295
Oncotarget. 2017 Feb 21;8(8):13048-13058
pubmed: 28055956
Cancer Res. 2014 Oct 15;74(20):5758-71
pubmed: 25261234
BMC Genomics. 2012 Aug 01;13:357
pubmed: 22849433
Mol Cancer. 2014 May 29;13:131
pubmed: 24884630
Methods. 2012 Feb;56(2):293-304
pubmed: 22285593
J Circ Biomark. 2015 Jul 17;4:7
pubmed: 28936243
Cancer Res. 2019 Jan 1;79(1):146-158
pubmed: 30401711
J Biol Chem. 2011 Apr 22;286(16):14383-95
pubmed: 21300796
J Vis Exp. 2012 Jan 09;(59):e3037
pubmed: 22257828
Nat Cell Biol. 2011 Apr;13(4):423-33
pubmed: 21423178
Elife. 2015 Jul 01;4:e07197
pubmed: 26132860
Nat Rev Drug Discov. 2017 Mar;16(3):203-222
pubmed: 28209991
Eur J Cancer. 2018 Nov;103:356-387
pubmed: 30100160
Science. 2008 Feb 29;319(5867):1244-7
pubmed: 18309083
Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):5003-8
pubmed: 21383194
Int J Mol Med. 2018 Dec;42(6):3009-3016
pubmed: 30221678
Nature. 2011 Jul 13;475(7355):201-5
pubmed: 21753850
BMC Genomics. 2013 May 10;14:319
pubmed: 23663360
PLoS One. 2019 Jan 4;14(1):e0210003
pubmed: 30608951
Oncology. 2017;92(6):360-370
pubmed: 28376502
Anticancer Res. 2002 Jul-Aug;22(4):2311-6
pubmed: 12174919
Int J Mol Sci. 2019 Feb 16;20(4):null
pubmed: 30781524
J Cell Mol Med. 2017 May;21(5):838-847
pubmed: 28233416
Biomark Med. 2018 Oct;12(10):1185-1196
pubmed: 30235938
Mol Cancer. 2014 Nov 26;13:256
pubmed: 25428807
J Cancer Res Ther. 2016 Jan-Mar;12(1):96-102
pubmed: 27072218
Oncotarget. 2017 Mar 7;8(10):17081-17091
pubmed: 28177881
Nat Med. 1998 May;4(5):594-600
pubmed: 9585234
BMC Genomics. 2018 Feb 14;19(1):146
pubmed: 29444662
Trends Biochem Sci. 2010 Jul;35(7):368-76
pubmed: 20395147
Br J Cancer. 2015 Jul 14;113(2):275-81
pubmed: 26057451
Cell Adh Migr. 2017 Mar 4;11(2):151-163
pubmed: 28166442
Cell Mol Life Sci. 2019 May;76(9):1697-1711
pubmed: 30694346
Biomark Insights. 2006;2:113-121
pubmed: 18079988
J Extracell Vesicles. 2017 Jun 20;6(1):1329476
pubmed: 28717422
J Extracell Vesicles. 2014 Dec 22;3:26913
pubmed: 25536934
Cell. 2019 Apr 4;177(2):428-445.e18
pubmed: 30951670
Cell. 2016 Mar 10;164(6):1226-1232
pubmed: 26967288
Oncotarget. 2017 Jul 29;8(42):72220-72226
pubmed: 29069781
Oncol Rep. 2016 Nov;36(5):3065-3071
pubmed: 27666412
Hum Mol Genet. 2015 Jul 1;24(13):3689-98
pubmed: 25832648
Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1145-1150
pubmed: 30779083
Bioessays. 2011 Oct;33(10):737-41
pubmed: 21932222
Nat Commun. 2013;4:2980
pubmed: 24356509
Nat Commun. 2018 Dec 19;9(1):5395
pubmed: 30568162
PLoS One. 2014 Apr 16;9(4):e95240
pubmed: 24740415
PLoS One. 2008;3(10):e3377
pubmed: 18852879
Cent Eur J Immunol. 2018;43(4):482-489
pubmed: 30799997
Cancer Biomark. 2018;22(2):283-299
pubmed: 29630521
Nat Cell Biol. 2009 Sep;11(9):1150-6
pubmed: 19684574
Nature. 2015 Nov 19;527(7578):329-35
pubmed: 26524530
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
Trends Cell Biol. 2015 Jun;25(6):364-72
pubmed: 25683921
Int J Nanomedicine. 2018 Nov 20;13:7727-7747
pubmed: 30538455
Biol Pharm Bull. 2015;38(9):1272-9
pubmed: 26179333
Int J Mol Sci. 2012;13(8):9545-71
pubmed: 22949815
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):E2110-6
pubmed: 22753494
Oncotarget. 2016 Nov 15;7(46):76250-76260
pubmed: 27788488
Cancer Cell. 2014 Nov 10;26(5):707-21
pubmed: 25446899
Mol Cell Proteomics. 2013 Feb;12(2):343-55
pubmed: 23161513
J Cell Biochem. 2018 May;119(5):4113-4119
pubmed: 29240249
Transl Oncol. 2019 Feb;12(2):191-199
pubmed: 30393102
Nat Rev Mol Cell Biol. 2018 Apr;19(4):213-228
pubmed: 29339798
Cell. 2018 Mar 22;173(1):20-51
pubmed: 29570994
J Extracell Vesicles. 2015 May 29;4:26760
pubmed: 26027894
Oncology. 2018;95(5):309-318
pubmed: 30138915
Curr Biol. 2011 May 10;21(9):779-86
pubmed: 21514161
Oncotarget. 2017 Jun 16;8(36):60149-60158
pubmed: 28947960
Int J Mol Sci. 2016 Feb 06;17(2):170
pubmed: 26861301
Oncotarget. 2016 Aug 2;7(31):50086-50098
pubmed: 27418137
Oncoscience. 2014 Mar 16;1(2):132-157
pubmed: 25594007
Int J Oncol. 2011 Dec;39(6):1353-7
pubmed: 21842121
Cell Mol Life Sci. 2018 Jan;75(2):193-208
pubmed: 28733901
PLoS One. 2016 Oct 19;11(10):e0160722
pubmed: 27760147
Oncotarget. 2017 Aug 24;8(60):101189-101202
pubmed: 29254156
Cancer Biol Ther. 2016 Oct 2;17(10):1062-1069
pubmed: 27611932
Bull Cancer. 2018 Apr;105(4):336-349
pubmed: 29496262
Cell Rep. 2014 Sep 25;8(6):1649-1658
pubmed: 25242326
PLoS One. 2014 Apr 04;9(4):e92921
pubmed: 24705249
Oncotarget. 2015 Mar 30;6(9):7262-79
pubmed: 25788261
Am J Pathol. 2017 Jul;187(7):1633-1647
pubmed: 28619275
PLoS One. 2018 Dec 27;13(12):e0209750
pubmed: 30589909
Nat Rev Genet. 2011 Feb;12(2):99-110
pubmed: 21245828
Future Oncol. 2017 Aug;13(18):1633-1647
pubmed: 28829193
J Clin Oncol. 2008 Dec 10;26(35):5668-70
pubmed: 19001346
Mol Cell. 2010 Jun 25;38(6):781-8
pubmed: 20620951
J Extracell Vesicles. 2015 May 14;4:27066
pubmed: 25979354
J Immunol. 2008 Mar 1;180(5):3081-90
pubmed: 18292531
Gene. 2014 Nov 1;551(1):55-64
pubmed: 25158130
Nature. 2003 Sep 25;425(6956):415-9
pubmed: 14508493
J Biol Chem. 2013 Apr 12;288(15):10849-59
pubmed: 23439645
Cancer Res. 2001 Jul 15;61(14):5562-9
pubmed: 11454708
Nat Rev Immunol. 2009 Aug;9(8):581-93
pubmed: 19498381
Oncotarget. 2015 Jun 20;6(17):15375-96
pubmed: 25944692
Cell Rep. 2016 May 3;15(5):978-987
pubmed: 27117408
Oncol Lett. 2016 Apr;11(4):2925-2933
pubmed: 27073578
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Clin Cancer Res. 2017 Nov 1;23(21):6744-6756
pubmed: 28751447
Genomics Proteomics Bioinformatics. 2015 Feb;13(1):17-24
pubmed: 25724326
Nat Commun. 2017 Feb 17;8:14448
pubmed: 28211508
Oncotarget. 2017 May 9;8(19):30859-30869
pubmed: 28415718
Sci Rep. 2016 Jan 20;6:19413
pubmed: 26786760
Nature. 2015 Jul 9;523(7559):177-82
pubmed: 26106858
J Biol Chem. 2012 May 4;287(19):15874-85
pubmed: 22396543
Angiogenesis. 2015 Jul;18(3):373-82
pubmed: 26040900
J Extracell Vesicles. 2018 Dec 18;8(1):1555410
pubmed: 30574280
Microvasc Res. 2018 Nov;120:21-28
pubmed: 29777792
BMC Cancer. 2017 Nov 09;17(1):730
pubmed: 29121858
Nucleic Acids Res. 2019 Jan 8;47(D1):D89-D93
pubmed: 30335161
J Extracell Vesicles. 2014 Sep 18;3:null
pubmed: 25317274
Oncotarget. 2017 Jul 25;8(30):49807-49823
pubmed: 28591704
Cell Death Dis. 2018 Oct 10;9(10):1037
pubmed: 30305607
Nat Rev Cancer. 2015 Jun;15(6):321-33
pubmed: 25998712
Mol Oncol. 2014 May;8(3):689-703
pubmed: 24593875
Biomed Pharmacother. 2018 Oct;106:1135-1143
pubmed: 30119180
Oncol Lett. 2016 Jul;12(1):488-494
pubmed: 27347170
J Exp Med. 1996 Mar 1;183(3):1161-72
pubmed: 8642258
PLoS One. 2010 Oct 20;5(10):e13515
pubmed: 20976003
PLoS One. 2012;7(9):e44398
pubmed: 22970209
Int J Cancer. 2019 May 1;144(9):2169-2180
pubmed: 30381824
PLoS One. 2014 Oct 17;9(10):e110314
pubmed: 25330373
Semin Cell Dev Biol. 2018 Jun;78:22-36
pubmed: 29258963
Am J Pathol. 2006 Jun;168(6):2014-26
pubmed: 16723715
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
J Extracell Vesicles. 2015 Jul 17;4:27031
pubmed: 26194179
Exp Ther Med. 2014 Jun;7(6):1757-1761
pubmed: 24926380
Semin Cell Dev Biol. 2017 Apr;64:107-115
pubmed: 27578007
Oncol Rep. 2012 Nov;28(5):1551-8
pubmed: 22895844
Clin Cancer Res. 2016 Aug 15;22(16):4057-66
pubmed: 26994146
Mol Ther Nucleic Acids. 2017 Sep 15;8:132-143
pubmed: 28918016
Biomed Res Int. 2014;2014:742831
pubmed: 24689054
Expert Rev Mol Diagn. 2015 Mar;15(3):375-84
pubmed: 25487540
Nucleic Acids Res. 2011 Sep 1;39(16):7223-33
pubmed: 21609964
Cold Spring Harb Perspect Med. 2016 Sep 01;6(9):null
pubmed: 27449973
Traffic. 2009 Jul;10(7):925-37
pubmed: 19490536
Nat Cell Biol. 2015 Jun;17(6):816-26
pubmed: 25985394

Auteurs

Valentin Vautrot (V)

INSERM 1231, Label Ligue National Contre le Cancer and Label d'excellence LipSTIC, Dijon, France.
University of Bourgogne Franche-Comté, EA 318, Besançon, France.
Anti-cancer Center Georges-François Leclerc, Dijon, France.

Gaëtan Chanteloup (G)

INSERM 1231, Label Ligue National Contre le Cancer and Label d'excellence LipSTIC, Dijon, France.
Faculty of Medicine, University of Burgundy-Franche-Comté, France.

Mohammed Elmallah (M)

INSERM 1231, Label Ligue National Contre le Cancer and Label d'excellence LipSTIC, Dijon, France.
Anti-cancer Center Georges-François Leclerc, Dijon, France.
Chemistry Department, Faculty of Science, Helwan University, 11795 Ain Helwan, Cairo, Egypt.

Marine Cordonnier (M)

INSERM 1231, Label Ligue National Contre le Cancer and Label d'excellence LipSTIC, Dijon, France.
Faculty of Medicine, University of Burgundy-Franche-Comté, France.

François Aubin (F)

University of Bourgogne Franche-Comté, EA 318, Besançon, France.
Centre Hospitalier Universitaire, Besançon, France.

Carmen Garrido (C)

INSERM 1231, Label Ligue National Contre le Cancer and Label d'excellence LipSTIC, Dijon, France.
Anti-cancer Center Georges-François Leclerc, Dijon, France.
Faculty of Medicine, University of Burgundy-Franche-Comté, France.

Jessica Gobbo (J)

INSERM 1231, Label Ligue National Contre le Cancer and Label d'excellence LipSTIC, Dijon, France.
Anti-cancer Center Georges-François Leclerc, Dijon, France.

Classifications MeSH